San Antonio Breast Cancer Symposium Review

This conference has already taken place.

As the second most common type of cancer affecting women, breast cancer has long been extremely well researched to that cure rates can be maximized and side effects mitigated. The Annual San Antonio Breast Cancer Symposium (SABC) has a group of esteemed and expert planners who survey various topics and research pursuits to determine what is salient to practicing clinicians. It's been established that community oncologists typically treat multiple types of cancer and cannot stay current on all of the key research findings.

For pricing information, see pricing tab below.

• Additional Info
• Agenda
• Pricing
• Speakers
• Location
• Accreditation & Credit Statements

Dates and Times

Start: 2/1/2025 7:15 AM
End: 2/1/2025 2:25 PM

Objectives

• Describe the latest and best practice for surgical management of breast cancer
• Explain how recent evidence affects overcoming resistance to endocrine therapies
• Identify optimal treatment of patients with HER2+ breast cancer
• Define how treatment of breast cancer patients with radiation therapy has advanced recently
• Articulate how new therapies influence the treatment of triple negative breast cancer
• Characterize what recent studies teach us about managing patients with familial risk of breast cancer

Agenda

Pricing

Tier	Price
RN	$40.00
APP	$65.00
MD and DO	$150.00
Other Healthcare Professional	$40.00
Residents, Fellow, and Advocates	$0.00

Speakers

• Therese Andraos, MD
  • Advances in Radiation Oncology
• Sasha Beyer, MD
  • De-Escalation in Medical Oncology, Radiation Oncology and Surgical Oncology
• Margaret Gatti-Mays, MD
  • Management of Treatment-Related Lung Toxicities in Patients with Breast Cancer
• Kevin Ho, MD
  • Management of Treatment-Related Lung Toxicities in Patients with Breast Cancer
• Kai Johnson, MD
  • Optimizing Treatment of Patients with HER2+ Breast
• Kevin Kalinsky, MD
  • Overcoming Endocrine Resistance in ER+ Breast Cancer
• Sara Myers, MD
  • De-Escalation in Medical Oncology, Radiation Oncology and Surgical Oncology
• Samilia Obeng-Gyasi, MD
  • Updates in the Surgical Management of Breast Cancer
• Dionisia Quiroga, DO
  • Advances in the Treatment of HER2 Low Breast Cancer
• Mark Robson, MD
  • Management of Patients with Inherited Risk for Breast Cancer
• Arya Mariam Roy, MD
  • New Directions in Breast Cancer Prevention
• Sagar Sardesai, MD
  • Emerging Trends in the Management of Triple-Negative Breast Cancer
• Gary Tozbikian, MD
  • Advances in the Treatment of HER2 Low Breast Cancer
• Robert Wesolowski, MD
  • De-Escalation in Medical Oncology, Radiation Oncology and Surgical Oncology

Panels

• Ask the Expert Panel: Case-Based Discussion of Dilemmas in Breast Cancer
  • Dr. Gilbert Bader, MD
  • Dr. Erin Burke, MD
  • Dr. Daniel Stover, MD
  • Dr. Rebekah Young, MD
• Ask the Expert Panel: Case-Based Discussion on Loco-Regional Dilemmas in Breast Cancer
  • Dr. Erin Burke, MD
  • Dr. Mathew Cherian, MBBS
  • Dr. Sachin Jhawar, MD
  • Dr. Sara Myers, MD
  • Dr. Michael Sorkin, MD

Location

Hilton Columbus at Easton
3900 Chagrin Dr.
Columbus, OH 43219

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.